Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · Mkt capMarket cap $43.07B · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2025 · Mkt cap
Decision snapshot: WDAY stock price vs INCY: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at INCY's multiple
Needs INCY P/E.
Implied fair value · at WDAY's multiple
Needs WDAY P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: WDAY FY 2026 (ended Jan 31, 2026) · INCY FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 94% equity / 6% debt · EV / Revenue 4.25x · EV / EBITDA 29.95x
Capital structure 94% equity / 6% debt · EV / Revenue 4.62x · EV / EBITDA 13.50x
WDAY carries the larger enterprise value at $40.62B against $23.73B; WDAY trades on the lower EV / Revenue multiple (4.25x vs 4.62x); INCY on the lower EV / EBITDA (13.50x vs 29.95x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
WORKDAY, INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
INCYTE CORPORATION · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.38x
0.29x
Net debt / EBITDA
Leverage against operating earnings
-1.81x
-0.90x
Cash and equivalents
Liquid reserves on the balance sheet
$5.44B
$3.10B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Salesforce, Inc.
WDAY vs CRM
Oracle Corporation
WDAY vs ORCL
INTUIT INC.
WDAY vs INTU
AUTOMATIC DATA PROCESSING INC
WDAY vs ADP
Paycom Software, Inc.
WDAY vs PAYC
AMGEN INC
WDAY vs AMGN
GILEAD SCIENCES, INC.
WDAY vs GILD
VERTEX PHARMACEUTICALS INC / MA
WDAY vs VRTX
REGENERON PHARMACEUTICALS, INC.
WDAY vs REGN
BIOGEN INC.
WDAY vs BIIB
$2.99B
$1.51B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
